Page last updated: 2024-08-16

thalidomide and epidermal growth factor

thalidomide has been researched along with epidermal growth factor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dagvadorj, J; Khuda, II; Koide, N; Komatsu, T; Naiki, Y; Noman, AS; Tumurkhuu, G; Yokochi, T; Yoshida, T	1

Other Studies

1 other study(ies) available for thalidomide and epidermal growth factor

Article	Year
Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation. Biochemical and biophysical research communications, 2008, Oct-03, Volume: 374, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Humans; Leukemia; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; p38 Mitogen-Activated Protein Kinases; Phosphorylation; ras Proteins; Thalidomide; Vascular Endothelial Growth Factor A	2008

Article

Year

Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation.

Biochemical and biophysical research communications, 2008, Oct-03, Volume: 374, Issue:4

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Humans; Leukemia; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; p38 Mitogen-Activated Protein Kinases; Phosphorylation; ras Proteins; Thalidomide; Vascular Endothelial Growth Factor A

2008